181 related articles for article (PubMed ID: 20339853)
1. The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.
Han SL; Xu C; Wu XL; Li JL; Liu Z; Zeng QQ
Int J Colorectal Dis; 2010 Jun; 25(6):695-702. PubMed ID: 20339853
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
Wu J; Lei L; Wang S; Gu D; Zhang J
J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
[TBL] [Abstract][Full Text] [Related]
3. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C
J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer.
He Z; Wu H; Jiao Y; Zheng J
Oncol Lett; 2015 Feb; 9(2):793-797. PubMed ID: 25624904
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression and Prognostic Significance of CD97 and its Ligand DAF in Human Cervical Squamous Cell Carcinoma.
He Y; Wang W; Xu L; Li L; Liu J; Feng M; Bu H
Int J Gynecol Pathol; 2015 Sep; 34(5):473-9. PubMed ID: 26107567
[TBL] [Abstract][Full Text] [Related]
7. The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas.
Liu Y; Chen L; Peng S; Chen Z; Gimm O; Finke R; Hoang-Vu C
Oncol Rep; 2005 Dec; 14(6):1413-20. PubMed ID: 16273233
[TBL] [Abstract][Full Text] [Related]
8. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.
Niu M; Xu S; Yang J; Yao D; Li N; Yan J; Zhong G; Song G
J Biol Chem; 2021; 296():100776. PubMed ID: 33992645
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD97 and CD55 in human medullary thyroid carcinomas.
Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C
Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of CD97 and CD55 levels in the differential diagnosis of tuberculous and malignant pleural effusions.
Wang C; Jie J; Li D; Liu Y; Gao J; Song L
Medicine (Baltimore); 2021 Jul; 100(30):e26771. PubMed ID: 34397724
[TBL] [Abstract][Full Text] [Related]
12. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
Hamann J; Vogel B; van Schijndel GM; van Lier RA
J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
[TBL] [Abstract][Full Text] [Related]
14. CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma.
Yin Y; Xu X; Tang J; Zhang W; Zhangyuan G; Ji J; Deng L; Lu S; Zhuo H; Sun B
Hepatology; 2018 Nov; 68(5):1865-1878. PubMed ID: 29704239
[TBL] [Abstract][Full Text] [Related]
15. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.
Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP
Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.
Durrant LG; Chapman MA; Buckley DJ; Spendlove I; Robins RA; Armitage NC
Cancer Immunol Immunother; 2003 Oct; 52(10):638-42. PubMed ID: 12811528
[TBL] [Abstract][Full Text] [Related]
17. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
Wobus M; Vogel B; Schmücking E; Hamann J; Aust G
Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.
Steinert M; Wobus M; Boltze C; Schütz A; Wahlbuhl M; Hamann J; Aust G
Am J Pathol; 2002 Nov; 161(5):1657-67. PubMed ID: 12414513
[TBL] [Abstract][Full Text] [Related]
20. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
